InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Johnson Shane Aaron, Vice-Président. Director active across 1 company, notably InMed Pharmaceuticals Inc.. In total, 3 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €25k. Activity tracked since 15 November 2021. The latest transaction was disclosed on 6 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Shane Aaron Johnson is Senior Vice President and General Manager of BayMedica LLC, a subsidiary of InMed Pharmaceuticals Inc. In this role, he oversees the operations and strategy of the company, ensuring growth and innovation.